Cora Sternberg, MD, FACP, Weill Cornell Medicine

Articles by Cora Sternberg, MD, FACP, Weill Cornell Medicine

Cora Sternberg, MD, FACP, Professor of Medicine, Division of Hematology and Medical Oncology, and Clinical Director of the Englander Institute for Precision Medicine, Weill Cornell, and Medicine NewYork-Presbyterian Hospital

ESMO 2020 Highlights With Cora Sternberg, MD, FACP

ByCora Sternberg, MD, FACP, Weill Cornell Medicine

October 30th 2020

TROPHY U-01 cohort 1 is a phase 2 open-label study of sacituzumab govitecan in patients with metastatic urothelial cancer and disease progression after both platinum-based regimens and checkpoint inhibitors.

Rapid Readouts: TROPHY-U-01 Cohort 1 Final Results

ByCora Sternberg, MD, FACP, Weill Cornell Medicine

October 14th 2020

Latest Updated Articles

Rapid Readouts: TROPHY-U-01 Cohort 1 Final Results
Published: October 14th 2020 | Updated:

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Oncology Fellows Presents a New Drug Cheat Sheet for Fellows

Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC

Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant